Brevan Howard Capital Management LP Agios Pharmaceuticals, Inc. Transaction History
Brevan Howard Capital Management LP
- $14.2 Billion
- Q3 2024
A detailed history of Brevan Howard Capital Management LP transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 10,727 shares of AGIO stock, worth $379,199. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,727
Previous 13,829
22.43%
Holding current value
$379,199
Previous $596,000
20.13%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding AGIO
# of Institutions
232Shares Held
58.1MCall Options Held
403KPut Options Held
469K-
Farallon Capital Management LLC San Francisco, CA5.66MShares$200 Million1.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.55MShares$196 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$172 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.74MShares$132 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$100 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.94B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...